Wordt geladen...
Nutlin-3 Enhances Sorafenib Efficacy in Renal Cell Carcinoma
The renal cell carcinoma (RCC) is one of the top ten cancers in USA. The renal tumors are highly angiogenic and are resistant to conventional interventions, particularly radiotherapy. The advent of multispecific tyrosine kinase inhibitor sorafenib has improved the progression-free survival in RCC, b...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4153352/ https://ncbi.nlm.nih.gov/pubmed/22006587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.20875 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|